Sivik Global Healthcare’s Elevance Health ELV Stock Holding History

Sivik Global Healthcare’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Hold	5,000	–	–	1.11%	32
2026 Q1	$1.46M	Buy	+5,000	New	+$1.64M	1.11%	32
2023 Q3	–	Sell	-15,000	Closed	-$6.66M	–	41
2023 Q2	$6.66M	Buy	15,000 +4,457	+42%	+$2.06M	1.56%	20
2023 Q1	$4.85M	Buy	10,543 +2,543	+32%	+$1.21M	2.08%	26
2022 Q4	$4.1M	Sell	8,000 -3,000	-27%	-$1.52M	1.93%	28
2022 Q3	$5M	Sell	11,000 -4,000	-27%	-$1.91M	2.78%	20
2022 Q2	$7.24M	Hold	15,000	–	–	4.11%	4
2022 Q1	$7.37M	Sell	15,000 -2,500	-14%	-$1.14M	3.04%	8
2021 Q4	$8.11M	Buy	+17,500	New	+$7.36M	3.48%	7
2021 Q1	–	Sell	-20,000	Closed	-$6.42M	–	51
2020 Q4	$6.42M	Buy	+20,000	New	+$6.14M	2.62%	22
2020 Q1	–	Sell	-27,500	Closed	-$8.31M	–	48
2019 Q4	$8.31M	Buy	27,500 +12,500	+83%	+$3.44M	3.08%	5
2019 Q3	$3.6M	Sell	15,000 -10,000	-40%	-$2.74M	1.82%	30
2019 Q2	$7.05M	Sell	25,000 -2,500	-9%	-$683K	1.71%	7
2019 Q1	$7.89M	Buy	27,500 +5,000	+22%	+$1.45M	2.91%	9
2018 Q4	$5.91M	Sell	22,500 -5,000	-18%	-$1.37M	3.19%	10
2018 Q3	$7.54M	Buy	27,500 +2,500	+10%	+$649K	2.69%	9
2018 Q2	$5.95M	Buy	25,000 +5,000	+25%	+$1.16M	2.29%	17
2018 Q1	$4.39M	Sell	20,000 -10,000	-33%	-$2.35M	2.05%	19
2017 Q4	$6.75M	Sell	30,000 -7,500	-20%	-$1.6M	2.51%	7
2017 Q3	$7.12M	Sell	37,500 -2,500	-6%	-$476K	2.42%	14
2017 Q2	$7.53M	Sell	40,000 -3,795	-9%	-$682K	2.75%	8
2017 Q1	$7.24M	Sell	43,795 -6,205	-12%	-$987K	3.37%	3
2016 Q4	$7.19M	Buy	+50,000	New	+$6.69M	3.43%	9
2016 Q1	–	Sell	-25,000	Closed	-$3.49M	–	61
2015 Q4	$3.49M	Buy	+25,000	New	+$3.44M	1.66%	27
2015 Q3	–	Sell	-35,000	Closed	-$5.75M	–	61
2015 Q2	$5.75M	Buy	35,000 +10,000	+40%	+$1.6M	1.99%	16
2015 Q1	$3.86M	Buy	25,000 +16,440	+192%	+$2.34M	1.31%	33
2014 Q4	$1.08M	Sell	8,560 -11,440	-57%	-$1.41M	0.44%	63
2014 Q3	$2.39M	Sell	20,000 -25,000	-56%	-$2.87M	1.09%	46
2014 Q2	$4.84M	Buy	45,000 +10,330	+30%	+$1.06M	2.44%	11
2014 Q1	$3.45M	Buy	+34,670	New	+$3.14M	2.15%	10

Other funds holding ELV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sivik Global Healthcare's ELV Position: Q2 2026 in Review

Sivik Global Healthcare held its Elevance Health (ELV) position steady in Q2 2026 at 5,000 shares worth $1.46M. The position accounts for 1.11% of the portfolio, ranked #32.

Sivik Global Healthcare first reported a position in ELV in Q1 2014 and has held it in 30 quarters since. The position peaked at $8.31M in Q4 2019. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Sivik Global Healthcare held 5,000 shares of Elevance Health worth $1.46M as of Q2 2026.
Sivik Global Healthcare left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 1.11% of Sivik Global Healthcare's portfolio in Q2 2026, its #32 holding.
Sivik Global Healthcare first reported a position in Elevance Health in Q1 2014 and has held it in 30 quarters since.
Sivik Global Healthcare's Elevance Health position peaked at $8.31M in Q4 2019.
417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.